Page last updated: 2024-10-31

mitotane and Porphyria, Acute Intermittent

mitotane has been researched along with Porphyria, Acute Intermittent in 1 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.

Research Excerpts

ExcerptRelevanceReference
"Mitotane therapy was discontinued but the attack of porphyria persisted for more than four months and included episodes with severe metabolic and neurologic toxicities."1.37[Mitotane as possible cause of acute intermittent porphyria]. ( von Eyben, FE, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
von Eyben, FE1

Other Studies

1 other study available for mitotane and Porphyria, Acute Intermittent

ArticleYear
[Mitotane as possible cause of acute intermittent porphyria].
    Ugeskrift for laeger, 2011, Sep-12, Volume: 173, Issue:37

    Topics: Adrenal Cortex Neoplasms; Antineoplastic Agents, Hormonal; Female; Humans; Middle Aged; Mitotane; Po

2011